MEMSCAP SA

MEMSCAP SA

4.59
EUR
0.00
(0.00%)
35.14MMarket Cap
Mar 31Next Earn
MEMSCAP SA
GETTEX:MSBA
(Gettex)

Recent

price

4.59

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
EUR
2.63
2.13
2.1
2.13
1.87
1.78
1.65
1.63
1.75
1.72
1.49
1.14
1.25
1.88
1.65
1.58
- -
Revenue per Share
-0.08
-0.43
-0.06
-0.21
0.03
0.09
0.02
-0.12
0.04
- -
-0.07
-0.04
0.14
0.29
0.18
0.12
- -
Basic EPS, GAAP
0.03
-0.08
-0.26
-0.22
0.19
0.17
0.11
0.01
0.04
0.08
0.13
0.21
-0.02
0.19
0.04
0.17
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
3.72
3.7
3.07
2.46
2.37
2.5
2.61
2.37
2.24
2.24
2.09
2.12
2.09
2.37
2.4
2.51
2.55
Book Value per Share
1.89
1.66
1.45
1.16
1.15
1.34
1.42
1.27
1.18
1.19
1.11
1.15
1.17
1.47
1.54
1.65
1.68
Tangible Book Value per Share
5
5
6
6
7
7
7
7
7
7
7
7
7
7
8
8
8
Basic Weighted Avg Shares
13
10
12
14
13
13
12
12
13
13
11
9
9
14
13
12
- -
Sales/Revenue/Turnover
0.24
-18.49
-12.22
-10.21
2.81
6.42
0.12
-5.4
4.32
1.03
-2.41
6.79
2.53
17.6
9.26
8.35
- -
Operating Margin (%)
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
- -
Depreciation Expense
- -
-2
- -
-1
- -
1
- -
-1
- -
- -
-1
- -
1
2
1
1
- -
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
55.56
130.77
- -
10.67
37.86
1.52
1.72
0.22
- -
Effective Tax Rate (%)
-2.98
-20.39
-2.68
-10
1.37
5.26
0.92
-7.07
2.04
-0.25
-4.9
-3.84
11.23
15.21
10.85
7.46
- -
Profit Margin (%)
5
3
5
4
4
5
5
5
5
5
5
5
6
8
9
10
10
Working Capital
2
2
2
2
1
1
1
1
6
6
5
5
5
5
4
4
4
LT Debt
19
17
19
17
17
18
19
17
17
17
16
16
16
18
18
19
19
Total Equity
0.13
- -
- -
- -
1.84
4.08
0.07
- -
1.14
-0.17
- -
2.28
0.66
10.56
4.72
4.1
- -
Return on Invested Capital (%)
-1.67
- -
- -
- -
1.35
3.67
0.74
- -
1.63
-0.38
- -
-0.9
5.3
10.32
6.61
4.45
- -
Return on Capital (%)
-2.09
-11.3
-1.86
-7.69
1.06
3.84
0.59
-4.6
1.56
-0.19
-3.38
-2.09
6.68
12.87
7.64
4.79
- -
Return on Common Equity (%)

Capital Structure

EUR

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
ST Debt
1
1
1
LT Borrowings
- -
- -
- -
LT Finance Leases
4
4
4
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
8
8
8
Market Capitalization
30
32
35

Working Capital

EUR

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
Total Current Assets
12
12
13
Cash, Cash Equivalents & STI
4
4
4
Accounts Receivable, Net
3
2
4
Inventories
5
5
5
Total Current Liabilities
3
2
3
Payables & Accruals
- -
- -
- -
ST Debt
1
1
1
Deferred Revenue
- -
- -
- -

Growth Rates

EUR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
0.86%
4.2%
4.21%
Free Cash Flow
-53.97%
-165.35%
269.88%
Net Income, GAAP
-1.36%
-85.17%
-34.93%
Sales/Revenue/Turnover
1.06%
4.3%
-5.32%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
13
2025
- -
- -
12
2026
- -
- -
- -

Semi-annual Earnings Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
0.18
2025
- -
- -
0.12
2026
- -
- -
- -

Semi-annual Dividends Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -
Business
Memscap S.A. specializes in designing, manufacturing, and marketing high precision micro-electro-mechanical systems (MEMS) based solutions primarily for the aerospace, defense, medical, and optical communications markets. Its core products include ultra-high precision pressure sensors and pressure transducers used in avionics systems such as air data computers, cabin pressure control, emergency systems, altimeters, and engine control; variable optical attenuator (VOA) chips for fiber optic communication networks; and a range of packaged components and modules. The company also offers medical pressure sensor solutions comprising reusable transducers coupled with disposable accessories, serving intensive care and dialysis applications, and maintains a portfolio of intellectual property including the registered trademark IOMA. Founded in November 1997 and headquartered in Crolles, France, Memscap operates globally and serves high-growth, high-value market segments. In recent developments, Memscap entered into a strategic development agreement with Parker Hannifin to customize its MEMS-based high-precision pressure sensors for aerospace airframe fluidic systems, expanding its reach into this segment beyond traditional avionics applications. The company is actively growing its product line in engine control systems following successful technical readiness reviews. Financially, Memscap reported steady performance in 2025 with robust net liquidity and a strong cash position, despite a challenging economic environment. Its strategic focus remains on profitable growth supported by advanced MEMS technology and operational efficiency enhancements, including advancing its engine control product line and maintaining leadership in aerospace and medical pressure sensing technologies. Memscap remains listed publicly and continuously invests in research and development to sustain technological advantages and serve its various industry segments with innovative MEMS-based solutions.